Chromos announces independent Multiple Sclerosis Advisory Board:
"Chromos Molecular Systems Inc. has formed a Multiple Sclerosis (MS) Advisory Board to guide the Company's development of a promising novel treatment for MS. Comprised of nationally and internationally recognized physicians, clinicians and scientists in the MS field, the MS Advisory Board will serve as an independent panel of experts regarding the development of CHR-1103 for the acute treatment of relapses (flares) associated with MS and other follow-on indications related to MS...."